Kazuki Matsuda

Assistant Professor

University of Tokyo

Japan

Research Interests

Explore related searches

Professors in Japan Professors in Immunology Immunology professors in Japan

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Kazuki Matsuda serves as an Assistant Professor at The University of Tokyo in Japan. His research notably encompasses the study of systemic sclerosis, exploring areas such as autoantibodies, clinical manifestations, and treatment responses. Recent publications highlight his work on the mechanisms of autoimmune diseases and the identification of potential biomarkers for various conditions.

Articles (19)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Collaborators (4)

Ayumi Yoshizaki

Graduate School of Medicine, The University of Tokyo

JAPAN

View details

Yuta Norimatsu

International University of Health and Welfare Narita Hospital

JAPAN

View details

Kazuma Mawatari

JAPAN

View details

Tomohisa Okamura

Associate Professor

University of Tokyo

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Kazuki Matsuda

Research Interests

Explore related searches

Contact this professor

About

Articles (19)

Unveiling the hidden syndrome: The enigma of anti-transcobalamin receptor autoantibodies

An open-label randomized parallel-group phase I study of the oral Bruton tyrosine kinase inhibitor tirabrutinib in systemic sclerosis

A case of anti-CD320 antibody-positive cutaneous arteritis accompanied by multiple cranial nerve symptoms

The Number of Nail Fold Capillaries and Nail Fold Bleedings Reflects the Clinical Manifestations of Systemic Sclerosis

Concurrence of bird-related hypersensitivity pneumonitis and systemic sclerosis-associated interstitial lung disease

A case of Darier's disease with a missense mutation in exon 8 of ATP2A2

Diversity and epitope spreading of anti‐RNA polymerase III antibodies in systemic sclerosis: a potential biomarker for skin and lung involvement

Reliability, validity, and sensitivity of the Japanese version of the University of California Los Angeles scleroderma clinical trial consortium gastrointestinal tract instrument: Application to efficacy assessment of intravenous immunoglobulin administration

Autoantibodies to nuclear valosin-containing protein-like protein: systemic sclerosis-specific antibodies revealed by in vitro human proteome

Rapid improvement of systemic sclerosis-associated intestinal pseudo-obstruction with intravenous immunoglobulin administration

Significance of anti-transcobalamin receptor antibodies in cutaneous arteritis revealed by proteome-wide autoantibody screening

Serum C-X-C Chemokine Ligand 1 Levels in Patients with Systemic Sclerosis: Relationship of Clinical and Laboratory Observations to Anti-CD20 Monoclonal Antibody Administration

Genital necrosis with cutaneous thrombosis after COVID‐19 mRNA vaccination

Interleukin-31 promotes fibrosis and T helper 2 polarization in systemic sclerosis

Development of a prediction model of treatment response in patients with cutaneous arteritis: Insights from a cohort of 33 patients

Serum heat shock protein 27 levels in patients with systemic sclerosis: a possible biomarker of skin sclerosis

Scrofuloderma arising from spermatic cord tuberculosis

Combined immunosuppressive therapy provides favorable prognosis and increased risk of cytomegalovirus reactivation in anti‐melanoma differentiation‐associated gene 5 antibody‐positive dermatomyositis

A case of trigeminal trophic syndrome responding to mirogabalin.

Collaborators (4)

Ayumi Yoshizaki

Yuta Norimatsu

Kazuma Mawatari

Tomohisa Okamura

Make your next move.